NCT02412761
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential Hypertension
See it on ClinicalTrials.gov ↗32 people
37.5%
62.5%
12 womenmiddle line = equal numbers20 men
- Phase
- NA
- Paid for by
- The University of Texas Health Science Center, Houston
- Finished
- 2016-07
- Health conditions
- Essential Hypertension
- Who could join
- Anyone
- Ages
- 9 Years – 22 Years
- Average age
- median 14 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 22 Years.”
Study titles and rules are shown in their original English.